Report Detail

Request for Sample of this report

Pharma & Healthcare Global Opioids Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4652142
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at US$ 9975 million in 2024 and is forecast to a readjusted size of USD 8823 million by 2031 with a CAGR of -1.8% during review period.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
This report is a detailed and comprehensive analysis for global Opioids Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Opioids Drug market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
Global Opioids Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
Global Opioids Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
Global Opioids Drug market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Opioids Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Opioids Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Opioids Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Market segment by Application
Pain Relief
Anesthesia
Others
Major players covered
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioids Drug, with price, sales quantity, revenue, and global market share of Opioids Drug from 2020 to 2025.
Chapter 3, the Opioids Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Opioids Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioids Drug.
Chapter 14 and 15, to describe Opioids Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Opioids Drug Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Oxycodone
    • 1.3.3 Hydromorphone
    • 1.3.4 Codeine
    • 1.3.5 Fentanyl
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Opioids Drug Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Pain Relief
    • 1.4.3 Anesthesia
    • 1.4.4 Others
  • 1.5 Global Opioids Drug Market Size & Forecast
    • 1.5.1 Global Opioids Drug Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Opioids Drug Sales Quantity (2020-2031)
    • 1.5.3 Global Opioids Drug Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Teva
    • 2.1.1 Teva Details
    • 2.1.2 Teva Major Business
    • 2.1.3 Teva Opioids Drug Product and Services
    • 2.1.4 Teva Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Teva Recent Developments/Updates
  • 2.2 Purdue Pharma
    • 2.2.1 Purdue Pharma Details
    • 2.2.2 Purdue Pharma Major Business
    • 2.2.3 Purdue Pharma Opioids Drug Product and Services
    • 2.2.4 Purdue Pharma Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Purdue Pharma Recent Developments/Updates
  • 2.3 Mallinckrodt
    • 2.3.1 Mallinckrodt Details
    • 2.3.2 Mallinckrodt Major Business
    • 2.3.3 Mallinckrodt Opioids Drug Product and Services
    • 2.3.4 Mallinckrodt Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Mallinckrodt Recent Developments/Updates
  • 2.4 Amneal Pharma
    • 2.4.1 Amneal Pharma Details
    • 2.4.2 Amneal Pharma Major Business
    • 2.4.3 Amneal Pharma Opioids Drug Product and Services
    • 2.4.4 Amneal Pharma Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Amneal Pharma Recent Developments/Updates
  • 2.5 Collegium
    • 2.5.1 Collegium Details
    • 2.5.2 Collegium Major Business
    • 2.5.3 Collegium Opioids Drug Product and Services
    • 2.5.4 Collegium Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Collegium Recent Developments/Updates
  • 2.6 J&J
    • 2.6.1 J&J Details
    • 2.6.2 J&J Major Business
    • 2.6.3 J&J Opioids Drug Product and Services
    • 2.6.4 J&J Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 J&J Recent Developments/Updates
  • 2.7 Endo
    • 2.7.1 Endo Details
    • 2.7.2 Endo Major Business
    • 2.7.3 Endo Opioids Drug Product and Services
    • 2.7.4 Endo Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Endo Recent Developments/Updates
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer Opioids Drug Product and Services
    • 2.8.4 Pfizer Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Pfizer Recent Developments/Updates
  • 2.9 INSYS
    • 2.9.1 INSYS Details
    • 2.9.2 INSYS Major Business
    • 2.9.3 INSYS Opioids Drug Product and Services
    • 2.9.4 INSYS Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 INSYS Recent Developments/Updates
  • 2.10 Mylan
    • 2.10.1 Mylan Details
    • 2.10.2 Mylan Major Business
    • 2.10.3 Mylan Opioids Drug Product and Services
    • 2.10.4 Mylan Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Mylan Recent Developments/Updates
  • 2.11 Hikma
    • 2.11.1 Hikma Details
    • 2.11.2 Hikma Major Business
    • 2.11.3 Hikma Opioids Drug Product and Services
    • 2.11.4 Hikma Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Hikma Recent Developments/Updates
  • 2.12 Egalet
    • 2.12.1 Egalet Details
    • 2.12.2 Egalet Major Business
    • 2.12.3 Egalet Opioids Drug Product and Services
    • 2.12.4 Egalet Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Egalet Recent Developments/Updates

3 Competitive Environment: Opioids Drug by Manufacturer

  • 3.1 Global Opioids Drug Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Opioids Drug Revenue by Manufacturer (2020-2025)
  • 3.3 Global Opioids Drug Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Opioids Drug by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Opioids Drug Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Opioids Drug Manufacturer Market Share in 2024
  • 3.5 Opioids Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Opioids Drug Market: Region Footprint
    • 3.5.2 Opioids Drug Market: Company Product Type Footprint
    • 3.5.3 Opioids Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Opioids Drug Market Size by Region
    • 4.1.1 Global Opioids Drug Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Opioids Drug Consumption Value by Region (2020-2031)
    • 4.1.3 Global Opioids Drug Average Price by Region (2020-2031)
  • 4.2 North America Opioids Drug Consumption Value (2020-2031)
  • 4.3 Europe Opioids Drug Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Opioids Drug Consumption Value (2020-2031)
  • 4.5 South America Opioids Drug Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Opioids Drug Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Opioids Drug Sales Quantity by Type (2020-2031)
  • 5.2 Global Opioids Drug Consumption Value by Type (2020-2031)
  • 5.3 Global Opioids Drug Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Opioids Drug Sales Quantity by Application (2020-2031)
  • 6.2 Global Opioids Drug Consumption Value by Application (2020-2031)
  • 6.3 Global Opioids Drug Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Opioids Drug Sales Quantity by Type (2020-2031)
  • 7.2 North America Opioids Drug Sales Quantity by Application (2020-2031)
  • 7.3 North America Opioids Drug Market Size by Country
    • 7.3.1 North America Opioids Drug Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Opioids Drug Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Opioids Drug Sales Quantity by Type (2020-2031)
  • 8.2 Europe Opioids Drug Sales Quantity by Application (2020-2031)
  • 8.3 Europe Opioids Drug Market Size by Country
    • 8.3.1 Europe Opioids Drug Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Opioids Drug Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Opioids Drug Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Opioids Drug Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Opioids Drug Market Size by Region
    • 9.3.1 Asia-Pacific Opioids Drug Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Opioids Drug Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Opioids Drug Sales Quantity by Type (2020-2031)
  • 10.2 South America Opioids Drug Sales Quantity by Application (2020-2031)
  • 10.3 South America Opioids Drug Market Size by Country
    • 10.3.1 South America Opioids Drug Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Opioids Drug Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Opioids Drug Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Opioids Drug Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Opioids Drug Market Size by Country
    • 11.3.1 Middle East & Africa Opioids Drug Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Opioids Drug Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Opioids Drug Market Drivers
  • 12.2 Opioids Drug Market Restraints
  • 12.3 Opioids Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Opioids Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Opioids Drug
  • 13.3 Opioids Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Opioids Drug Typical Distributors
  • 14.3 Opioids Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Opioids Drug. Industry analysis & Market Report on Opioids Drug is a syndicated market report, published as Global Opioids Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Opioids Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo